Home / TWIST2 Knockout Cell Lines

TWIST2 Knockout Cell Lines

Gene: TWIST2

Official Full Name: twist family bHLH transcription factor 2provided by HGNC

Gene Summary: The protein encoded by this gene is a basic helix-loop-helix type transcription factor and shares similarity with Twist. This protein may inhibit osteoblast maturation and maintain cells in a preosteoblast phenotype during osteoblast development. This gene may be upregulated in certain cancers. Mutations in this gene cause focal facial dermal dysplasia 3, Setleis type. Two transcript variants encoding the same protein have been found. [provided by RefSeq, Apr 2014]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO05825 TWIST2 Knockout cell line (HeLa) Human TWIST2 1:3~1:6 Negative Online Inquiry
KO05826 TWIST2 Knockout cell line (HEK293) Human TWIST2 1:3~1:6 Negative Online Inquiry
KO05827 TWIST2 Knockout cell line (A549) Human TWIST2 1:3~1:4 Negative Online Inquiry

Background

TWIST2 Gene Knockout Cell Lines are specifically engineered cellular models designed to study the function and behavior of the TWIST2 gene, which is critical in various biological processes including embryogenesis and cellular differentiation. By employing the CRISPR-Cas9 gene-editing technology, these cell lines have been created to provide researchers with a reliable platform to explore the phenotypic consequences of TWIST2 gene disruption.

The key mechanism behind the TWIST2 Gene Knockout Cell Lines involves targeted editing of the TWIST2 gene, leading to a complete loss of function. This knockout allows researchers to assess the gene's role in specific pathways and cellular processes, particularly those related to tumorigenesis, developmental disorders, and cellular migration. Mechanistically, researchers can utilize these models to elucidate how the absence of TWIST2 influences gene expression profiles, protein interactions, and downstream cellular signaling.

From a scientific perspective, the ability to study the TWIST2 gene in a knockout model is invaluable for research and clinical applications. Understanding TWIST2's involvement in pathologies, such as congenital malformations and certain cancers, can guide the development of targeted therapies and inform diagnostic approaches. In particular, these models help elucidate the gene's contribution to processes such as epithelial-mesenchymal transition, a critical stage in cancer metastasis.

One unique advantage of TWIST2 Gene Knockout Cell Lines is their specificity and fidelity. Unlike traditional gene silencing techniques, such as siRNA, CRISPR-based knockouts provide a permanent gene alteration, allowing for consistent long-term studies. This stability offers researchers more robust and reproducible data, essential for advancing scientific understanding and therapeutic development.

Researchers and clinicians will find the TWIST2 Gene Knockout Cell Lines to be a valuable resource in their quest to unravel the complexities of gene function and regulation. These cell lines not only enhance experimental reproducibility but also facilitate the discovery of pathways and potential interventions in diseases influenced by TWIST2.

Our company is committed to advancing genomic technologies and providing researchers with high-quality, reliable tools that support innovative biomedical research. By choosing our TWIST2 Gene Knockout Cell Lines, you gain access to cutting-edge gene-editing capabilities that propel your research forward.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.